United States · 
What does Frazier Healthcare Partners invest in?
Frazier Healthcare Partners invests most often at Series B and Series A (56% of the rounds on record), in sectors such as Health-tech, Medicine and Therapeutic.
Frazier Healthcare Partners highlights
- 01
102 rounds on record
- 02
Mostly Series B and Series A: 56% of its rounds
- 03
Sole investor in 3 rounds, median $20M
- 04
21 exits from the portfolio
What they do
The Frazier Growth Buyout team is the preferred partner to profitable healthcare companies.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- Health-techMedicineTherapeutic
- Based in
- Seattle, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first102 appearances
- 2019
6 rounds
- Sept
- May
- Apr
- Mar
- Feb
- Jan
- 2017
3 rounds
- Dec
- Apr
- Mar
- 2015
6 rounds
- Oct
- Jul
- Mar
- Feb
- Feb
- Feb
- 2014
6 rounds
- Dec
- Oct
- Sept
- Jun
- Apr
- Jan
- 2013
4 rounds
- Sept
- Jul
- Mar
- Feb
- 2012
4 rounds
- Aug
- Apr
- Jan
- Jan
- 2011
5 rounds
- Nov
- Nov
- Jul
- Feb
- Feb
- 2010
9 rounds
- Sept
- Aug
- Jul
- Jun
- Jun
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration10 named
ANAlan N. FrazierMember of the Issuer's affiliated advisor, Frazier Management, L.L.C.iFiling they signed
BJBen Joseph MagnanoMember of the General PartneriFiling they signed
BKBrian Kingston MorfittMember of the General PartneriFiling they signed
BMBrian MagnanoMember of the General PartneriFiling they signed
JNJames N. TopperMember of the Issuers' affiliated advisor, Frazier Management, L.L.C.iFiling they signed
NJNader Jafari NainiMember of the General PartneriFiling they signed
NRNathan Robert EveryMember of the General PartneriFiling they signed
PJPatrick J. HeronMember of the Issuer's affiliated advisor, Frazier Management, L.L.C.iFiling they signed
RNRobert N. MoreMember of the general partneriFiling they signed
SRSteve Ray BaileyChief Financial Officer & Chief Compliance OfficeriForm ADV
We also hold 94 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$7.7Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Frazier Management, L.L.C.
- SEC number
- CRD 157324
Funds on its Form ADV
17 private funds, $4.7B in gross assets · filed Mar 2024
Private equity 16Venture 1
- Frazier Healthcare Growth Buyout Fund IX, L.P.Private equity116 investors$1.1B
- FH Sunrise Co-Investment I, L.P.Private equity43 investors$715M
- FH CSF Holdings, LLCPrivate equity40 investors$651M
- Frazier Healthcare Growth Buyout Fund X, L.P.Private equity100 investors$430M
- Frazier Healthcare Growth Buyout Fund X PV, L.P.Private equity46 investors$420M
- Frazier Healthcare Growth Buyout Fund IX PV, L.P.Private equity26 investors$338M
- Frazier Healthcare Growth Buyout Fund VIII, L.P.Private equity48 investors$337M
- Mercury Fortuna Buyer, LLCPrivate equity17 investors$225M
- Frazier Healthcare Growth Buyout Fund VIII PV, L.P.Private equity23 investors$173M
- Frazier Healthcare VII, L.P.Private equity39 investors$89M
And 7 more on the filing.
Who backs their funds
2 LPs on record in Frazier Healthcare Partners's funds
- Committed
- $237M
- Funds
- 5
- Vintages
- 1996 to 2025
The institutions that put money into its funds, which the firm then invests in companies.Source: the pension's own report, latest Mar 2026.
- California State Teachers Retirement System2 funds$147M
Fund Vintage Committed Frazier Healthcare Growth XI 2025 $100M Frazier Healthcare Ventures V 2005 $47M 
Washington State Investment Board3 funds$90MFund Vintage Committed Frazier Healthcare IV 2001 $40M Frazier Healthcare III 1998 $40M Frazier Healthcare II 1996 $10M
What they claim to have backed
From their own portfolio page (on their website)
2 of 46 we have independently watched raise
Pharma Packager PCIUsrenalcareAdare Pharma SolutionsAdarepharmasolutionsAgilitihealthAlteonhealthBravohealthBrightspringhealthBusinessCaravel Autism HealthCaravel Autism HealthCaravel ‘hasn’t skippedCaravelautismComprehensive Pharmacy Services,CorrectcaresolutionsCpspharmCsafeglobalEffectiveschoolsolutionsElevatepfsEptamFrazier-backed TCGRx acquiresGsmsHopcoKnipperKohlberg and MubadalaKonovoLabscoLeitersLeiters Acquires FacilityLuxinfusionMatrix Medical NetworkMatrixcareMatrixmedicalnetworkMyairlifeParataPatheonPciPentechealthRevspringincSolismammoTridentcareTriimagingUniteddermpartnersUniteddigestiveUrldefenseVaticahealth
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed21 in all
PatientKeeperBought by HCAUndisclosedSept 2014
PreCision DermatologyBought by Valeant Pharmaceuticals International$500MFeb 2014
StromedixBought by Biogen Idec$750MFeb 2014
Rempex PharmaceuticalsBought by The Medicines Company$464MDec 2013
BarosenseBought by Boston ScientificUndisclosedJul 2013
Zonare Medical SystemsBought by Mindray Medical International$105MJun 2013
Portola PharmaceuticalsListed$100MMay 2013
Incline TherapeuticsBought by The Medicines CompanyUndisclosedDec 2012
Calibra MedicalBought by Johnson & JohnsonUndisclosedJul 2012
BARRX MedicalBought by Covidien$325MNov 2011
Clovis OncologyListed$130MNov 2011
Calypso MedicalBought by Varian Medical SystemsUndisclosedSept 2011
Ascension OrthopedicsBought by Integra LifeSciences Holdings$65MSept 2011
Calistoga PharmaceuticalsBought by Gilead Sciences$375MFeb 2011
Marcadia BiotechBought by RocheUndisclosedDec 2010
XoftBought by iCAD$73MDec 2010
Alnara PharmaceuticalsBought by Eli LillyUndisclosedJul 2010
FlowCardiaBought by C. R. BardUndisclosedMay 2010
Intradigm CorporationBought by Silence TherapeuticsUndisclosedDec 2009
Primaeva MedicalBought by Syneron Medical$30MOct 2009
The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records.